Learn More
Medchemexpress LLC Lenvatinib | 417716-92-8 | 99.8% | 1 G

Supplier: Medchemexpress LLC HY10981200MG
Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor. It inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, demonstrating potent antitumor activities. This compound shows antiproliferative activity and growth inhibition in various cell lines.
- Inhibits VEGFR2, VEGFR3, and VEGFR1
- Inhibits PDGFRα, PDGFRβ, and FGFR1
- Inhibits KIT and RET
- Demonstrates antiproliferative activity
- Available as a solid form
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.